Follow US:
UC Riverside-led study identifies role played by an immune signaling molecule in regulating memory function in the normal and injured brain
The first class of fellows begins training in the Coachella Valley’s Betty Ford Center and Eisenhower Medical Center on July 1
UC Riverside-led study calls for culturally tailored approaches to encourage this neglected population to seek behavioral health treatment
UC Riverside biomedical scientist Marcus Kaul explains
Telehealth visits can be conducted on a cell phone, tablet, or pad device, allowing even individuals without a computer or internet to be seen by a UCR Health physician
UC Riverside physicists demonstrate “self-interacting dark matter” model can be tested using astronomical observations of Draco and Fornax
Brandon Brown is an associate professor in the Center for Healthy Communities in the School of Medicine
UC Riverside researchers’ mouse studies also show how a common nutrient can help babies of alcoholic moms
Nearly 70 graduates were accepted into residency programs of their choice in 2020
Over the past few years, biochemist John Jefferson Perry at the University of California, Riverside, has collaborated on a number of projects with Atomwise Inc., a company that uses artificial intelligence, or AI, for drug discovery. Now Perry and the company have formed a joint venture called Theia Biosciences. Perry’s...
UC Riverside mouse study provides insights into how pathological fear memory in PTSD could be suppressed
UC Riverside School of Medicine to lead engagement project in eastern Coachella Valley
UC Riverside-led study could inform the design of engineered nano-shells used in drug delivery
UC Riverside will lead collaborative effort at developing scalable quantum computers
UC Riverside-led rat study finds an immune receptor in the hippocampus is responsible for the onset of the disease after brain injuries
Zinc excess in the body correlates with oxidative stress
XMM-2599 lived fast and died young, says UC Riverside-led international team
Brandon Brown is an associate professor in the School of Medicine at UC Riverside
UC Riverside-led research has applications in ultrafast and spin-based nanoscale devices
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
